Abstract
Caspase-1 is a key enzyme in the inflammasome that turns on the inflammation cascade. It has been implicated in a variety of disease conditions, including gout, rheumatoid arthritis and inflammatory diseases. Gold complexes have long been studied for their anti-inflammatory properties. The active site of caspase-1 contains a cysteine thiolate, and given that sulfur is aurophilic, we hypothesized that gold complexes would inhibit caspase-1. In this work, we examined a series of gold(I) molecular species for inhibition of caspase-1. It was found that many of the complexes were effective inhibitors at the nanomolar range, with the most effective being PMe(3)AuCl (K(I) = 8 nM) and PPh(3)AuCl (K(I) = 9 nM). This highlights the value of gold(I) complexes as drug molecules that target cysteine-dependent proteins for disease states.